Vigil Neuroscience, Inc.
VIGL
$1.54
-$0.13-7.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -84.26M | -82.60M | -83.84M | -82.78M | -82.64M |
| Total Depreciation and Amortization | 453.00K | 453.00K | 449.00K | 447.00K | 399.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.96M | 10.47M | 9.87M | 9.20M | 8.78M |
| Change in Net Operating Assets | 22.62M | 23.09M | 3.31M | 3.08M | 3.10M |
| Cash from Operations | -51.22M | -48.59M | -70.21M | -70.06M | -70.36M |
| Capital Expenditure | -5.00K | -18.00K | -65.00K | -182.00K | -674.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.77M | 11.61M | 43.54M | 20.51M | -64.46M |
| Cash from Investing | 8.76M | 11.59M | 43.48M | 20.33M | -65.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | -2.00K | -12.00K | -23.00K |
| Issuance of Common Stock | 9.68M | 5.30M | 5.30M | 5.88M | 911.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 19.81M | 19.81M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 29.49M | 25.11M | 5.30M | 5.87M | 888.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.97M | -11.90M | -21.43M | -43.86M | -134.61M |
